Work

Phase I clinical trials of ticilimumab: Tumor responses are sufficient but not necessary for prolonged survival

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.8036

Authors: C. A. Bulanhagui, A. Ribas, D. Pavlov, V. Bozon, A. Sharma, J. Gomez-Navarro, L. Camacho

Institutions: Pfizer (United States), Ronald Reagan UCLA Medical Center, UCLA Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2264905259

Cites:

Cited by: 13

Related to: 10